How can Pharma & Healthcare Collaborate in a Financially Sustainable, Scalable & Privacy-Preserving Manner?
Finding and connecting with suitable patients, especially those who are undiagnosed, misdiagnosed or miscoded, in a scalable, sustainable and privacy-preserving manner, is central to the success of pharmaceutical companies, both in terms of improving patient outcomes and maximizing revenues. Therefore, collaboration with healthcare providers who assess and treat these patients is essential to achieving this success. However, stringent privacy regulations prevent pharmaceutical companies from collaborating with healthcare providers at scale.
Learn how Pangaea overcomes these challenges by providing a single product platform for characterizing patients for 7,000 conditions, helping to find and connect to more undiagnosed, misdiagnosed and miscoded patients without transacting data. This is demonstrated through a clinically proven success story, in which Pangaea enabled collaboration between two global pharmaceutical companies and the UK’s NHS to find 6 times more undiagnosed and miscoded patients with a hard-to-diagnose condition, cancer cachexia. This led to a 50% reduction in treatment costs, enhanced resource optimization, increased revenues and improved patient outcomes, all while ensuring privacy compliance.
